IJHS
Interprofessional Journal of Health Sciences
formerly Bulletin of Health, Science and Technology (BHST)
https://ijhs.rsu.ac.th
ISSN (Print) 2672-9628
ISSN (Online) 2672-9423
Interprofessional Journal of Health Sciences. Vol.17 No.2 , July - December 2019.
PREPARATION OF SUSTAINED RELEASE DICLOFENAC SODIUM TABLETS
USING CHITOSAN AND POLYVINYLPYRROLIDONE K90
AS COMBINED BINDING AGENTS
Abstract
Sustained release diclofenac sodium (DS) granules were prepared by granulation of DS powder and a poorly water-soluble diluent, dibasic calcium phosphate (DCP), with the binding solution of a swellable polymer, chitosan (CS), in various concentrations. Dissolution profiles of the prepared granules were studied. The granules containing DS, DCP and CS in the ratios of 10:10:0.1 and 10:5:0.1 were chosen to compress into tablets using various contents of a disintegrant, croscarmellose sodium (Ac-Di-Solâ). Their dissolution profiles were studied and very slow tablet dissolution rates were observed. Polyvinylpyrrolidone K90 (PVP) and CS were used as the combined binder system to granulate the 10:5 DS:DCP mixture in order to modify the dissolution rates of the DS tablets. The 10:5 DS:DCP granules prepared by using various ratios of CS to PVP, as combined binders, were compressed into tablets using Ac-Di-Solâ in the concentrations of 1% and 2% as disintegrant. The effects of PVP and Ac-Di-Solâ contents on dissolution of the prepared DS tablets were investigated. It was found that the usage of the combined binders, CS and PVP, provided faster tablet dissolution than did the usage of CS alone as binder. The dissolution enhancing effect of Ac-Di-Solâ on tablet dissolution was more prominent in the DS tablets containing low content of PVP but was less significant in the tablets consisted of PVP in high content. Optimum contents of PVP and Ac-Di-Solâ, employed in the tablet formulation, were recognized as the important factor in developing the sustained release DS tablet having the most possible required dissolution profile.
Keywords: Sustained release tablets, diclofenac sodium, polyvinylpyrrolidone, chitosan